We offer the industry’s largest unit dose oral solids portfolio – with more products on the way.
Support adherence to USP general chapter <800> with unit dose products
American Health Packaging offers a large selection of antineoplastic and hazardous drugs as part of an industry-leading portfolio of unit-dose products. This document serves as a reference for those treatments, as defined by the National Institute of Occupational Safety and Health (NIOSH), that are produced by AHP in a unit-dose package. Products are listed based on their NIOSH classification:
Table of Contents
Group 1: Antineoplastic drugs
(AHFS Classification 10:00) ASHP/AHFS DI 2016]
Many of these drugs may pose a reproductive risk for susceptible populations.
Group 2: Non-antineoplastic drugs
These meet one or more of the NIOSH criteria for hazardous drugs. Some of these drugs may pose a reproductive risk for susceptible populations.
Group 3
Primarily pose a reproductive risk to men and women who are actively trying to conceive and women who are pregnant or breastfeeding, because some of these drugs may be present in breast milk.
